Expression of cathepsins B, D and L in mouse corneas infected with Pseudomonas aeruginosa

European Journal of Biochemistry

Volumn 268, Issue 24, 2001, Pages 6408-6416

  Dong, Zhong ^a   Katar, Malkhan ^a   Linebaugh, Bruce E ^a   Sloane, Bonnie F ^a   Berk, Richard S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cathepsin; Extracellular matrix; Murine; Proteinases; Pseudomonas keratitis

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN L;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; ENZYME ACTIVITY; ENZYME ASSAY; GRAM NEGATIVE INFECTION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; CATHEPSIN B; CATHEPSIN D; CATHEPSINS; CORNEA; CYSTEINE ENDOPEPTIDASES; DNA PRIMERS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; PSEUDOMONAS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; MURINAE; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0035663160     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0014-2956.2001.02607.x     Document Type: Article

References (61)

1. Post-operative uveitis
2. Experimental Pseudomonas keratitis in the rabbit: Bacteriologic, clinical, and microscopic observations
3. The immune system in experimental Pseudomonas keratitis. Model and early effects
4. Genetic control of the murine corneal response to Pseudomonas aeruginosa
5. Genetic regulation of the murine corneal and non-corneal response to P. aeruginosa
6. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive
7. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases
8. Kinetics of serum and ocular antibody responses in susceptible mice that received a secondary corneal infection with Pseudomonas aeruginosa
9. Monoclonal antibodies provide protection against ocular Pseudomonas aeruginosa infection
10. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection
11. In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naive and immunized mice
12. Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa
13. Plasminogen activators and inhibitors in the corneas of mice infected with Pseudomonas aeruginosa
14. Proteinases 1: Lysosomal cysteine proteinases
15. Cathepsin D: The lysosomal aspartic proteinase
16. Molecular cloning and sequencing of cDNA for rat cathepsin L
17. Proteolytic cleavage of human fibrinogen by cathepsin B
18. Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L
19. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues
20. Identification of renal cathepsin B as a human prorenin-processing enzyme
21. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA)
22. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus
23. Rat procathepsin B. Proteolytic processing to the mature form in vitro
24. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells
25. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles
26. Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro
27. Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: Amino-acid-sequence identities with procathepsin L
28. Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass
29. Fluorescent microplate assay for cancer cell-associated cathepsin B
30. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D
31. Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro
32. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L
33. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
34. Human cathepsin B1. Purification and some properties of the enzyme
35. Cathepsin B, Cathepsin H, and cathepsin L
36. Human tumour cathepsin B. Comparison with normal liver cathepsin B
37. Expression of cysteine proteases in extraembryonic tissues during mouse embryogenesis
38. Biological and diagnostic role of cathepsin D
39. The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L
40. The purification and properties of cathepsin L from rabbit liver
41. Cathepsin L. A new proteinase from rat-liver lysosomes
42. Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro) cathepsin L and a cathepsin L-like 70 kDa proteinase
43. Collagenolytic/gelatinolytic enzymes in corneal wound healing
44. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins
45. Lysosomal cysteine proteases: More than scavengers
46. Cathepsin B and human tumor progression
47. Cathepsin D in the malignant progression of neoplastic diseases
48. Expression of cathepsin L in human tumors
49. Cathepsin B, cathepsin C and arylamidase in rabbit cornea
50. Immunohistochemical localization of cathepsin D in ocular tissues
51. Localization of cathepsin D in rat ocular tissues. An immunohistochemical study
52. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Haras oncogene
53. Cathepsin D in breast cancer: A tissue marker associated with metastasis
54. Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines
55. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells
56. Gene regulation and extracellular functions of procathepsin L
57. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma
58. Identification of two new exons and multiple transcription start points in the 5′-untranslated region of the human cathepsin-B-encoding gene
59. Autocatalytic processing of recombinant human procathepsin B is a bimolecular process
60. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism
61. Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase